Littérature scientifique sur le sujet « Major adverse lower limb events »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Major adverse lower limb events ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Major adverse lower limb events"
Bonaca, Marc P., Naomi M. Hamburg et Mark A. Creager. « Contemporary Medical Management of Peripheral Artery Disease ». Circulation Research 128, no 12 (11 juin 2021) : 1868–84. http://dx.doi.org/10.1161/circresaha.121.318258.
Texte intégralStone, Patrick A., Stephanie N. Thompson, David Williams, Zachary AbuRahma, Luke Grome, Haley Schlarb et Ali F. AbuRahma. « Biochemical markers in patients with open reconstructions with peripheral arterial disease ». Vascular 24, no 5 (10 juillet 2016) : 461–68. http://dx.doi.org/10.1177/1708538115611302.
Texte intégralGuédon, Alexis F., Jean-Baptiste De Freminville, Tristan Mirault, Nassim Mohamedi, Bastien Rance, Natalie Fournier, Jean-Louis Paul, Emmanuel Messas et Guillaume Goudot. « Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events ». JAMA Network Open 5, no 12 (8 décembre 2022) : e2245720. http://dx.doi.org/10.1001/jamanetworkopen.2022.45720.
Texte intégralFashandi, Anna Z., J. Hunter Mehaffey, Robert B. Hawkins, Irving L. Kron, Gilbert R. Upchurch et William P. Robinson. « Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication ». Journal of Vascular Surgery 68, no 6 (décembre 2018) : 1817–23. http://dx.doi.org/10.1016/j.jvs.2018.06.193.
Texte intégralMehaffey, James H., Robert Hawkins, Anna Fashandi, Margret C. Tracci, Kenneth Cherry, Irving Kron, Gilbert Upchurch et William P. Robinson. « Lower Extremity Bypass Is Associated with Lower Short-Term Major Adverse Limb Events and Equivalent Major Adverse Cardiac Events Compared with Endovascular Intervention in A National Cohort with Critical Limb Ischemia ». Journal of Vascular Surgery 65, no 1 (janvier 2017) : e4-e5. http://dx.doi.org/10.1016/j.jvs.2016.10.018.
Texte intégralHabib, Salim, Othman Abdul-Malak, Michael Madigan, Karim Salem et Mohammad Eslami. « Completion Imaging Use After Lower Extremity Bypass and Association With Major Adverse Limb Events ». Journal of Vascular Surgery 76, no 3 (septembre 2022) : e40-e41. http://dx.doi.org/10.1016/j.jvs.2022.06.070.
Texte intégralSingh, Kuldeep, Amandeep Juneja, Tushar Bajaj, Christian Voto, Jonathan Schor, Saqib Zia et Jonathan Deitch. « Single Tertiary Care Center Outcomes After Lower Extremity Cadaveric Vein Bypass for Limb Salvage ». Vascular and Endovascular Surgery 54, no 5 (3 juin 2020) : 430–35. http://dx.doi.org/10.1177/1538574420925586.
Texte intégralNiiranen, Oskari, Juha Virtanen, Ville Rantasalo, Amer Ibrahim, Maarit Venermo et Harri Hakovirta. « The Association between Major Adverse Cardiovascular Events and Peripheral Artery Disease Burden ». Journal of Cardiovascular Development and Disease 11, no 6 (21 mai 2024) : 157. http://dx.doi.org/10.3390/jcdd11060157.
Texte intégralMehaffey, J. Hunter, Robert B. Hawkins, Anna Fashandi, Kenneth J. Cherry, John A. Kern, Irving L. Kron, Gilbert R. Upchurch et William P. Robinson. « Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention ». Journal of Vascular Surgery 66, no 4 (octobre 2017) : 1109–16. http://dx.doi.org/10.1016/j.jvs.2017.04.036.
Texte intégralSunitha Therese, S., et N. Gayathri. « LOWER EXTREMITY PHERIPHERALARTERIAL DISEASE - AN UPDATE ». International Journal of Advanced Research 10, no 02 (28 février 2022) : 1049–52. http://dx.doi.org/10.21474/ijar01/14311.
Texte intégralThèses sur le sujet "Major adverse lower limb events"
Teyssières, Salle Laurence. « Artériopathie des membres inférieurs chez le patient vivant avec un diabète de type 2 : marqueurs du risque et impact des thérapeutiques ». Electronic Thesis or Diss., Limoges, 2024. http://www.theses.fr/2024LIMO0031.
Texte intégralDespite diagnostic and therapeutic advances in the management of cardiovascular disease, it remains the leading cause of mortality in people living with type 2 diabetes (T2D). While coronary artery disease is increasingly screened for and managed optimally, peripheral artery disease remains underdiagnosed and undertreated, despite diabetes predisposes to more atypical, earlier, and severe forms. In individuals with T2D, the measurement of the ankle-brachial index (ABI), a validated screening tool, may be biased due to the presence of medial arterial calcification (MAC). In a population of 1119 asymptomatic patients with T2D, we demonstrated that the presence of ultrasound-detected MAC was independently associated with the occurrence of Major Adverse Cardiovascular Events (MACE) and Major Adverse Lower limb Events (MALE), regardless of the ABI. In the entire cohort, MAC appears as a better risk predictor than high ABI, often considered as a proxy for MAC. Beyond screening and risk estimation, we investigated the impact of different therapies on the peripheral arterial risk of patients living with T2D. The introduction of sodium-glucose cotransporter-2 (SGLT2) inhibitors, with proven cardio-renal protective effects, re-launched the debate on the link between diuretics and peripheral arterial risk. Our group's meta-analysis highlighted the need to expand literature. Among the 5 included studies, we showed a significant increase in the risk of amputation associated with diuretic use (OR=1.73, p<0.001). Subsequently, we conducted a retrospective observational study involving 1309 patients with T2D. In multivariable analysis, diuretics were significantly associated with the occurrence of MALE after adjustment for propensity score (aHR=1.66; 1.08-2.56, p=0.020) and inverse probability of treatment weighting analysis (aHR=1.76; 1.67-1.84, p<0.001). We identified at-risk profiles with diuretics treatment. In subgroup analysis, the risk of MALE with diuretics was significantly increased with abnormal ABI (<0.90 or 1.40) (aHR=2.29, interaction p=0.02). Loop or thiazide diuretics were associated with an increased risk, but not potassium-sparing diuretics. The third part of the work focused on the XATOA registry in patients with diabetes. The COMPASS trial demonstrated the benefit of double antithrombotic therapy (aspirin and rivaroxaban 2.5mg twice daily) on MACE and MALE in patients with stable cardiovascular disease. The results of this randomized controlled trial were confirmed by real-life data from the XATOA registry. The decisions that drive to double antithrombotic therapy prescription werecomparable between diabetic and non diabetic patients. The benefit on MACE and MALE was similar to that observed in the COMPASS trial.Our work highlights the need to assess peripheral arterial risk in people with T2D, use appropriate assessment tools and define therapies suited to the level of risk
Livres sur le sujet "Major adverse lower limb events"
Sunderkötter, Cord, et Luis Requena. Panniculitides. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0165.
Texte intégralStolker, Robert Jan, et Felix van Lier. Choice and interpretation of preoperative investigations. Sous la direction de Jonathan G. Hardman. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0041.
Texte intégralChapitres de livres sur le sujet "Major adverse lower limb events"
Yli-Ikkelä, Riku, Aki Rintala, Anna Köyhäjoki, Harto Hakonen, Hilkka Korpi, Mirjami Kantola, Sari Honkanen et al. « Effectiveness of Robot-Assisted Lower Limb Rehabilitation on Balance in People with Stroke : A Systematic Review, Meta-analysis, and Meta-regression ». Dans Communications in Computer and Information Science, 101–16. Cham : Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-59091-7_7.
Texte intégralOrrapin, Saritphat. « Cardiovascular Complications Related to Lower Limb Revascularization and Drug-Delivering Technology in Peripheral Arterial Disease ». Dans Cardiovascular Diseases [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.107973.
Texte intégralLittle, Michael B. « Anesthesia for Amputation Surgery ». Dans Vascular Anesthesia Procedures, 259–74. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780197506073.003.0018.
Texte intégralShahid, Monica, Nunzio Franco et Laxmi Sistla. « Voyaging to Safety : Anticoagulation in Peripheral Artery Disease and Limb Revascularisation ». Dans Anticoagulation - An Update [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.112773.
Texte intégralSunderkötter, Cord, et Luis Requena. « Panniculitides ». Dans Oxford Textbook of Rheumatology, 1418–25. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0165_update_003.
Texte intégralMazzolai, Lucia, Victor Aboyans et Marianne Brodmann. « Diabetes and lower extremity arterial disease ». Dans ESC CardioMed, 944–46. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0222.
Texte intégralJimenez, Juan Carlos, et Samuel Eric Wilson. « Major Adverse Limb Events and Mortality in Patients with Peripheral Artery Disease : The COMPASS Trial ». Dans 50 Landmark Papers Every Vascular and Endovascular Surgeon Should Know, 193–97. CRC Press, 2020. http://dx.doi.org/10.1201/9780429434020-39.
Texte intégralLane, Giulia I., Colby A. Dixon, M. Louis Moy et Cynthia S. Fok. « A Midurethral Sling to Reduce Incontinence After Vaginal Prolapse Repair ». Dans 50 Studies Every Urologist Should Know, 227–32. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190655341.003.0040.
Texte intégralAl Shakarchi, Julien. « Rivaroxaban in Peripheral Artery Disease After Revascularization (VOYAGER) ». Dans 50 Studies Every Vascular Surgeon Should Know, sous la direction de Julien Al Shakarchi et Andrew Garnham, 15–20. Oxford University Press, 2023. http://dx.doi.org/10.1093/med/9780197637906.003.0003.
Texte intégralSousa-Uva, Miguel, et Stuart J. Head. « Special conditions : revascularization ». Dans ESC CardioMed, 935–38. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0219.
Texte intégralActes de conférences sur le sujet "Major adverse lower limb events"
He, Yongtian, David Eguren, Trieu Phat Luu et Jose L. Contreras-Vidal. « Risk and adverse events related to lower-limb exoskeletons ». Dans 2017 International Symposium on Wearable & Rehabilitation Robotics (WeRob). IEEE, 2017. http://dx.doi.org/10.1109/werob.2017.8383850.
Texte intégralFernandes, Lucca Ferdinando Queiroz, Matheus Procópio Guimarães, Diógenes Emanuel Dantas da Silva, Pedro Henrick Guimarães Carvalho, Iury Hélder Santos Dantas, Daniel Vicente de Siqueira Lima Junior, Luíza Alves Monteiro Torreão Villarim et Bianca Etelvina Santos de Oliveira. « Multiple sclerosis associated with adalimumab treatment in psoriatic arthritis : a case report ». Dans XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.607.
Texte intégralWang, Yajuan, Antonio Ferreira, Bradley B. Keller, Marc Simon et James F. Antaki. « Effect of Continuous-Flow Left Ventricular Assist Device on Cardiac Function : Simulation Study With a Biventricular Computer Model ». Dans ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53784.
Texte intégralRapports d'organisations sur le sujet "Major adverse lower limb events"
Philosoph-Hadas, Sonia, Peter Kaufman, Shimon Meir et Abraham Halevy. Signal Transduction Pathway of Hormonal Action in Control and Regulation of the Gravitropic Response of Cut Flowering Stems during Storage and Transport. United States Department of Agriculture, octobre 1999. http://dx.doi.org/10.32747/1999.7695838.bard.
Texte intégralFinancial Markets Report - Second Quarter 2023. Banco de la República, juillet 2024. http://dx.doi.org/10.32468/rmf.eng2-trim.2023.
Texte intégral